BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 10557073)

  • 1. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N; Crespo P; Bustelo XR
    Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TC21 and Ras share indistinguishable transforming and differentiating activities.
    Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ
    Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
    Rosário M; Paterson HF; Marshall CJ
    Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
    Huff SY; Quilliam LA; Cox AD; Der CJ
    Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
    Cox AD; Brtva TR; Lowe DG; Der CJ
    Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
    Saez R; Chan AM; Miki T; Aaronson SA
    Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution.
    Kimmelman A; Tolkacheva T; Lorenzi MV; Osada M; Chan AM
    Oncogene; 1997 Nov; 15(22):2675-85. PubMed ID: 9400994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling.
    Klockow B; Ahmadian MR; Block C; Wittinghofer A
    Oncogene; 2000 Nov; 19(47):5367-76. PubMed ID: 11103938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
    Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
    Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors.
    Vargiu P; De Abajo R; Garcia-Ranea JA; Valencia A; Santisteban P; Crespo P; Bernal J
    Oncogene; 2004 Jan; 23(2):559-68. PubMed ID: 14724584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.
    Rey I; Taylor-Harris P; van Erp H; Hall A
    Oncogene; 1994 Mar; 9(3):685-92. PubMed ID: 8108110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.
    Carboni JM; Yan N; Cox AD; Bustelo X; Graham SM; Lynch MJ; Weinmann R; Seizinger BR; Der CJ; Barbacid M
    Oncogene; 1995 May; 10(10):1905-13. PubMed ID: 7761092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal images of growth-factor-induced activation of Ras and Rap1.
    Mochizuki N; Yamashita S; Kurokawa K; Ohba Y; Nagai T; Miyawaki A; Matsuda M
    Nature; 2001 Jun; 411(6841):1065-8. PubMed ID: 11429608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway.
    Esteve P; Embade N; Perona R; Jiménez B; del Peso L; León J; Arends M; Miki T; Lacal JC
    Oncogene; 1998 Oct; 17(14):1855-69. PubMed ID: 9778052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanine nucleotide exchange factors: activators of Ras superfamily proteins.
    Overbeck AF; Brtva TR; Cox AD; Graham SM; Huff SY; Khosravi-Far R; Quilliam LA; Solski PA; Der CJ
    Mol Reprod Dev; 1995 Dec; 42(4):468-76. PubMed ID: 8607978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways.
    Hernandez-Muñoz I; Malumbres M; Leonardi P; Pellicer A
    Oncogene; 2000 May; 19(23):2745-57. PubMed ID: 10851075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.